Basilea Pharmaceutica
BSLN.SW
#6399
Rank
A$0.88 B
Marketcap
$73.04
Share price
-0.71%
Change (1 day)
20.40%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: A$18.87 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are A$0.18 Billion. In 2023 the company made an earning of A$18.87 Million a decrease over its 2022 earnings that were of A$19.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023A$18.87 M-5.02%
2022A$19.87 M-276.18%
2021-A$11.28 Million-55.31%
2020-A$25.24 Million-28%
2019-A$35.05 Million-27.06%
2018-A$48.06 Million62.13%
2017-A$29.64 Million-60.94%
2016-A$75.87 Million-19.67%
2015-A$94.45 Million48.25%
2014-A$63.71 Million12.95%
2013-A$56.41 Million-35.16%
2012-A$87 Million-5.75%
2011-A$92.31 Million-152.57%
2010A$0.17 B-199.59%
2009-A$0.18 Billion-15.54%
2008-A$0.21 Billion22.84%
2007-A$0.17 Billion60.07%
2006-A$0.11 Billion85.69%
2005-A$57.18 Million-43.04%
2004-A$0.11 Billion47.04%
2003-A$68.27 Million-34.06%
2002-A$0.11 Billion